Commercial genomics inquiry response

Commercial genomics inquiry response

Sanger Institute's response to the UK House of Commons Select Committee inquiry into commercial genomic testing

Genomics is becoming increasingly popular and accessible owing to the availability of commercial at-home DNA testing kits. However, there are concerns that the commercial genomics industry is largely unchecked.

The House of Commons Science and Technology Committee launched an inquiry into commercial genomic testing to look at what safeguards need to be put in place to protect those who get tested.

The inquiry explored the standards required of commercial genomics companies, the ability of genomic tests to provide accurate health results, the potential implications for the NHS and the data protection measures required to ensure the secure storage and sharing of sensitive data.

To read the Sanger Institute’s full response to this inquiry, please click download the PDF below.